Ocular Therapeutix (NASDAQ:OCUL) Price Target Increased to $15.00 by Analysts at Piper Sandler

Ocular Therapeutix (NASDAQ:OCUL – Free Report) had its price target raised by Piper Sandler from $10.00 to $15.00 in a report issued on Monday, Benzinga reports. The firm currently has an overweight rating on the biopharmaceutical company’s stock. A number of other equities research analysts also recently commented on the stock. Bank of America started […]

Related Keywords

New York ,United States ,Montreal ,Quebec ,Canada ,America ,Piper Sandler ,Antonyc Mattessich ,Harvest Investment Services ,Securities Exchange Commission ,Ocular Therapeutix Inc ,Sg Americas Securities ,Rafferty Asset Management ,Ocular Therapeutix Company Profile ,York State Common Retirement Fund ,Ocular Therapeutix ,Free Report ,Moderate Buy ,Summer Road Llc ,Exchange Commission ,Investment Services ,Asset Management ,Montreal Can ,Get Free Report ,Resure Sealant ,Ocular Therapeutix Daily ,